(Q41975797)

14 October 2017

title

Should dopamine agonist treatment for prolactinomas be life-long? (English)

1 reference

14 October 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB00288.X

26 October 2022

author name string

G. Faglia

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1674680

26 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1674680

26 October 2022

publication date

1 March 1991

1 reference

full work available at URL

14 October 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2265.1991.tb00288.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB00288.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.1991.tb00288.x/fullpdf

26 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB00288.X

26 October 2022

published in

Clinical Endocrinology

1 reference

14 October 2017

volume

34

1 reference

14 October 2017

issue

3

1 reference

14 October 2017

page(s)

173-174

1 reference

Bromocriptine treatment reduces the cell size in human macroprolactinomas: a morphometric study

14 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB00288.X

Spontaneous pregnancies in hyperprolactinemic women

26 October 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB00288.X

Cabergoline: long-acting oral treatment of hyperprolactinemic disorders

26 October 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB00288.X

Necrotic changes in prolactinomas after long term administration of bromocriptine

26 October 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB00288.X

Effect of dopamine agonist withdrawal after long-term therapy in prolactinomas. Studies with high-definition computerised tomography

26 October 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB00288.X

Effects of a new prolactin inhibitor, CV 205-502, in the treatment of human macroprolactinomas

26 October 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB00288.X

Longitudinal evaluation of patients with untreated prolactin-secreting pituitary adenomas.

26 October 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB00288.X

The natural history of idiopathic hyperprolactinemia.

26 October 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB00288.X

Pregnancy and the hyperprolactinemic woman

26 October 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB00288.X

Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study

26 October 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB00288.X

Bromocriptine treatment of microprolactinomas: evidence of stable prolactin decrease after drug withdrawal

26 October 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB00288.X

Bromocriptine treatment of macroprolactinomas: studies on the time course of tumor shrinkage and morphology

26 October 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB00288.X

Resistance to bromocriptine in prolactinomas

26 October 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB00288.X

Rapid Changes of Prolactinoma Volume after Withdrawal and Reinstitution of Bromocriptine*

26 October 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB00288.X

Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural, and morphometric study

26 October 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB00288.X

Withdrawal of bromocriptine after long-term therapy for macroprolactinomas; effect on plasma prolactin and tumour size

26 October 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB00288.X

Advances in the biosciences

26 October 2022

20

69

321

Winkelmann W.

1988

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB00288.X

26 October 2022

Identifiers

1 reference

14 October 2017

1 reference